• Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact
Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer
  • Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact

Archives

Monthly Archive for: "August, 2020"
 Nascent Biotech Inc Completes $740,000 Equity Round of Funding
 0
By Nascent Biotech
In News
Posted August 24, 2020

Nascent Biotech Inc Completes $740,000 Equity Round of Funding

SAN DIEGO, CA / ACCESSWIRE / August 24, 2020 / Nascent Biotech, Inc (OTCQB:NBIO) announced today that it is closing on a direct private placement with aggregate proceeds of $740,000. The proceeds [...]

READ MORE
 Nascent Biotech Reduces Liabilities by Over 1.8 Million Dollars
 0
By Nascent Biotech
In Corporate News, News, Press Releases
Posted August 11, 2020

Nascent Biotech Reduces Liabilities by Over 1.8 Million Dollars

SAN DIEGO, CA / ACCESSWIRE / August 11, 2020 / Nascent Biotech, Inc. (OTCQB:NBIO) Announced today that It has significantly reduced its liabilities through stock conversion and payment of accrued [...]

READ MORE
 Nascent Biotech & Manhattan BioSolutions Participate In a Panel Discussion On The TB Vaccine Development For COVID-19
 0
By Nascent Biotech
In News
Posted August 4, 2020

Nascent Biotech & Manhattan BioSolutions Participate In a Panel Discussion On The TB Vaccine Development For COVID-19

SAN DIEGO, CA / ACCESSWIRE / August 4, 2020 / Nascent Biotech, Inc (OTCQB:NBIO), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat cancers and [...]

READ MORE
© NASCENT BIOTECH, INC. ALL RIGHTS RESERVED.